Literature DB >> 7417768

Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.

R Enat, S Pollack, Y Ben-Arieh, E Livni, D Barzilai.   

Abstract

Severe intrahepatic cholestasis occurred in a patient after taking nitrofurantoin, ampicillin, and cloxacillin. As only nitrofurantoin was known to cause cholestasis she was given cloxacillin again two years later. The cholestasis reappeared at once. A macrophage inhibition factor test confirmed that cloxacillin was the offending drug. Cloxacillin should be added to the growing list of drugs causing cholestasis. Inadvertent rechallenge with hepatototoxic drugs might be prevented by routine use of the macrophage inhibition factor test.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417768      PMCID: PMC1601139          DOI: 10.1136/bmj.280.6219.982

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  22 in total

Review 1.  Hepatic drug reactions.

Authors:  V Perez; F Schaffner; H Popper
Journal:  Prog Liver Dis       Date:  1972

2.  Hepatic injury associated with penicillin therapy.

Authors:  L I Goldstein; K G Ishak
Journal:  Arch Pathol       Date:  1974-08

3.  Oxacillin-induced hepatic dysfunction.

Authors:  W E Dismukes
Journal:  JAMA       Date:  1973-11-19       Impact factor: 56.272

4.  Broad-spectrum penicillins in enteric infections of children.

Authors:  J D Nelson; K C Haltalin
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

5.  Carbenicillin therapy for pseudomonas infections.

Authors:  G P Bodey; J P Whitecar; E Middleman; V Rodriguez
Journal:  JAMA       Date:  1971-10-04       Impact factor: 56.272

6.  Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections.

Authors:  H C Neu; H Swarz
Journal:  Ann Intern Med       Date:  1969-11       Impact factor: 25.391

7.  Lupoid hepatitis following administration of penicillin. Case report and immunological studies.

Authors:  J P Girard; B Haenni; R Bergoz; Y Kapanci; A Cruchaud
Journal:  Helv Med Acta       Date:  1967-12

8.  Elevated SGOT levels after carbenicillin.

Authors:  D W Gump
Journal:  N Engl J Med       Date:  1970-06-25       Impact factor: 91.245

9.  Macrophage migration inhibition test using guinea-pig macrophages and human lymphocytes.

Authors:  D A Rajapakse; L E Glynn
Journal:  Nature       Date:  1970-05-30       Impact factor: 49.962

10.  Abnormal serum transaminase levels after parenteral ampicillin and carbenicillin administration.

Authors:  A K Knirsch; E J Gralla
Journal:  N Engl J Med       Date:  1970-05-07       Impact factor: 91.245

View more
  7 in total

1.  Severe cholestatic hepatitis following cloxacillin treatment.

Authors:  S Goland; S D Malnick; R Gratz; E Feldberg; D Geltner; Z M Sthoeger
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

Review 2.  Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

Authors:  B M Devereaux; D H Crawford; P Purcell; L W Powell; H P Roeser
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study.

Authors:  Ashley R Maiuri; Bronlyn Wassink; Jonathan D Turkus; Anna B Breier; Theresa Lansdell; Gurpreet Kaur; Sarah L Hession; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2017-07-07       Impact factor: 4.030

Review 4.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

5.  Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis.

Authors:  J F Dowsett; T Gillow; A Heagerty; M Radcliffe; R Toadi; I Isle; R C Russell
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

Review 6.  Nafcillin-associated hepatotoxicity. Report of a case and review of the literature.

Authors:  M E Presti; C G Janney; B A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

7.  Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

Authors:  B H Stricker; J W Van den Broek; J Keuning; W Eberhardt; H G Houben; M Johnson; A P Blok
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.